Annovis Bio, Inc.
ANVS- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001477845
No open-market purchases or sales by Annovis Bio, Inc. insiders were filed in the last 90 days; 61 institutions reported holding it in 13F filings for Q2 2026, worth $20.2M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Annovis Bio, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 40
- +5 vs. Q3 2024
- Shares held
- 1.58M
- +396.7K (+33.6%) vs. Q3 2024
- Total value
- $7.93M
- −$1.58M (−16.6%) vs. Q3 2024
- New holders
- 9
- 13 more added
- Sold out
- 4
- 8 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ANVS on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 61 | $20.2M |
| Q1 2026 | 56 | $10.5M |
| Q4 2025 | 53 | $14.7M |
| Q3 2025 | 42 | $4.19M |
| Q2 2025 | 42 | $3.93M |
| Q1 2025 | 44 | $3.13M |
| Q4 2024 | 40 | $7.93M |
| Q3 2024 | 35 | $9.50M |
| Q2 2024 | 31 | $5.67M |
| Q1 2024 | 31 | $14.3M |
| Q4 2023 | 36 | $22.5M |
| Q3 2023 | 30 | $10.6M |
| Q2 2023 | 28 | $18.3M |
| Q1 2023 | 23 | $11.6M |
| Q4 2022 | 23 | $9.93M |
| Q3 2022 | 25 | $10.0M |
| Q2 2022 | 26 | $8.73M |
| Q1 2022 | 24 | $11.9M |
| Q4 2021 | 32 | $19.6M |
| Q3 2021 | 38 | $36.2M |
| Q2 2021 | 57 | $109.0M |
| Q1 2021 | 31 | $23.1M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Annovis Bio, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Caitong International Asset Management Co., Ltd | 79 | $397 | 0.00% | +79 | New |
| EverSource Wealth Advisors, LLC | 83 | $417 | 0.00% | 00.0% | Unchanged |
| Bank of America Corp | 84 | $423 | 0.00% | −5,996−98.6% | Reduced |
| WR Wealth Planners, LLC | 150 | $755 | 0.00% | 00.0% | Unchanged |
| Game Plan Financial Advisors, LLC | 200 | $1.00K | 0.00% | 00.0% | Unchanged |
| Rhumbline Advisers | 350 | $1.76K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 403 | $2.03K | 0.00% | +403 | New |
| Advisor Group Holdings, Inc. | 502 | $2.52K | 0.00% | −698−58.2% | Reduced |
| Bokf, NA | 555 | $2.71K | 0.00% | 00.0% | Unchanged |
| DiNuzzo Private Wealth, Inc. | 1,000 | $5.03K | 0.00% | +1,000 | New |
| Morgan Stanley | 1,300 | $6.54K | 0.00% | −50−3.7% | Reduced |
| R Squared Ltd | 1,520 | $7.65K | 0.01% | +1,520 | New |
| Tower Research Capital LLC (TRC) | 1,768 | $8.89K | 0.00% | −1,319−42.7% | Reduced |
| JPMorgan Chase & Co | 3,800 | $19.1K | 0.00% | 00.0% | Unchanged |
| Bryn Mawr Trust Co | 9,393 | $47.2K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 9,746 | $49.0K | 0.00% | 00.0% | Unchanged |
| Wealthspire Advisors, LLC | 10,050 | $50.6K | 0.00% | +50+0.5% | Added |
| Creative Planning | 10,460 | $52.6K | 0.00% | +10,460 | New |
| Two Sigma Investments, LP | 10,923 | $54.9K | 0.00% | +10,923 | New |
| XTX Topco Ltd | 11,653 | $58.6K | 0.00% | +11,653 | New |
| Atria Wealth Solutions, Inc. | 13,002 | $65.4K | 0.00% | +13,002 | New |
| Lokken Investment Group LLC | 18,235 | $91.7K | 0.04% | +6,000+49.0% | Added |
| Bank of New York Mellon Corp | 19,058 | $95.9K | 0.00% | −10.0% | Reduced |
| Spears Abacus Advisors LLC | 20,000 | $100.6K | 0.00% | 00.0% | Unchanged |
| Bridgeway Capital Management, LLC | 21,400 | $107.6K | 0.00% | −700−3.2% | Reduced |
| Sterling Investment Advisors, Ltd. | 23,974 | $120.6K | 0.03% | −10,500−30.5% | Reduced |
| Group One Trading, L.P. | 26,206 | $131.8K | 0.00% | −26,561−50.3% | Reduced |
| Greenwich Wealth Management LLC | 31,951 | $161.0K | 0.01% | +15,476+93.9% | Added |
| Northern Trust Corp | 32,780 | $164.9K | 0.00% | +10,846+49.4% | Added |
| State Street Corp | 38,435 | $193.3K | 0.00% | +2,400+6.7% | Added |
| Wescott Financial Advisory Group, LLC | 41,607 | $209.3K | 0.02% | 00.0% | Unchanged |
| UBS Group AG | 48,736 | $245.1K | 0.00% | +46,889+2,538.7% | Added |
| Cubist Systematic Strategies, LLC | 51,347 | $258.3K | 0.00% | +51,347 | New |
| Susquehanna International Group, LLP | 55,312 | $278.2K | 0.00% | +23,792+75.5% | Added |
| Jane Street Group, LLC | 68,107 | $342.6K | 0.00% | +47,901+237.1% | Added |
| Merit Financial Group, LLC | 98,516 | $495.5K | 0.01% | +71,816+269.0% | Added |
| Geode Capital Management, LLC | 99,564 | $501.0K | 0.00% | +450+0.5% | Added |
| BlackRock, Inc. | 111,979 | $563.3K | 0.00% | +10,484+10.3% | Added |
| Citadel Advisors LLC | 215,207 | $1.08M | 0.00% | +112,515+109.6% | Added |
| Vanguard Group Inc | 466,277 | $2.35M | 0.00% | +86,022+22.6% | Added |
| Quest Partners LLC | 0 | $0 | 0.00% | −46,002−100.0% | Sold out |
| D. E. Shaw & Co., Inc. | 0 | $0 | 0.00% | −24,410−100.0% | Sold out |
| Bank of Montreal | 0 | $0 | 0.00% | −13,500−100.0% | Sold out |
| Simplex Trading, LLC | 0 | $0 | 0.00% | −8,605−100.0% | Sold out |